Named catch-up gap: management identifies where the company visibly lags peers or its own potential, and is already clos
The model's full reasoning — Q1 2018 call → NOWe need to determine if management identifies a specific, named dimension on which the company currently underperforms relative to peers, industry norms, or its own potential, and describes work already underway to close that gap, with management treating closing it as a meaningful source of improvement that does not depend on market conditions getting better. We need to scan the transcript for any such self-diagnosis. The talk is about earnings, growth, deposits, credit, etc. They mention various improvements, but we need a specific gap. For example, do they say "our efficiency ratio is higher than peers, we are working to reduce it"? Or "our retail deposit growth is underperforming"? Or "our mortgage business is underperforming"? They mention Ally Home: "We've got some work to do on Ally Home in improving that offering, and I expect us to make a lot of great progress on mortgage overall this year." That is a gap: Ally Home is underperforming, but is it named specifically? They say "We've got some work to do on Ally Home" – that is a vague gap, but do they quantify it or describe closing work? They say they expect progress. But is it a specific measurable gap? They don't quantify how much it lags. Also, is it a significant source of improvement? Probably not defined. They also mention "We're making prudent investments in technology and product expansion" but not a specific gap. Look for other mentions: "Ally Invest is making good progress" but no gap. "We're focused on getting our new businesses, namely Ally Invest and Ally Home, scaled up" – that's aspirational, not a defined underperformance vs peers. Another possible: They mention "We still see share buybacks as an attractive capital deployment alternative." Not a gap. They mention "Our deposit growth enables us to bring down capital markets funding" – that's a strength. They mention expense growth: "Noninterest expense moved higher. Expense growth is largely driven by both business growth, as well as our product diversification initiative." That's not a gap, just growth. They mention "adjusted efficiency ratio was 50%... We'd expect that to fall below 50% for the remainder of the year." That is a specific metric: efficiency ratio. But do they say they underperform peers? They don't benchmark it. They just expect it to fall. That's just guidance.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| MEG | Montrose Environmental Group, Inc. | Q3 2023 | 2023-11-08 | C+ |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| SWK | Stanley Black & Decker, Inc. | Q1 2023 | 2023-05-04 | D |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| ADNT | Adient plc | Q1 2018 | 2018-01-29 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| STKL | SunOpta Inc. | Q2 2017 | 2017-08-09 | C+ |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| PPG | PPG Industries, Inc. | Q1 2017 | 2017-04-20 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| SXT | Sensient Technologies Corporation | Q4 2016 | 2017-02-10 | A |
| BC | Brunswick Corporation | Q3 2016 | 2016-10-28 | B+ |
| SON | Sonoco Products Company | Q4 2015 | 2016-02-11 | B |
HOLX · Q4 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly diagnosing Cynosure’s commercial organization as the specific underperforming dimension (salesforce turnover, recruiting, and productivity lagging behind the company’s international business and its own best operations). They then describe concrete, already-executing actions—stopping voluntary turnover, rehiring high performers, instituting 90-day reviews, new compensation, and building “Cynosure 2.0”—as the mechanism to close the gap.
STKL · Q2 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management identifying a specific named gap in the bars segment, where operational issues at a particular facility are causing inefficient production and gross margin losses. They describe a rapid recovery team already executing systematic identification and correction of these issues, treating the gap as closable through their own operational efforts rather than external market improvements — this aligns with the criteria for a meaningful source of improvement.
ADNT · Q1 2018 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly naming the Seat Structures and Mechanisms (SS&M) business as the specific underperforming dimension. They state it is “destroyed shareholder value” when run as currently organized, and that it is “impacting our financial results” with “significant impact.